- $10.67bn
- $8.79bn
- $1.31bn
- 85
- 17
- 97
- 73
Annual income statement for UiPath, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 336 | 608 | 892 | 1,059 | 1,308 |
| Cost of Revenue | |||||
| Gross Profit | 278 | 542 | 723 | 879 | 1,112 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 853 | 718 | 1,393 | 1,407 | 1,473 |
| Operating Profit | -517 | -110 | -501 | -348 | -165 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -517 | -94.7 | -511 | -318 | -75.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -520 | -92.4 | -526 | -328 | -89.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -520 | -92.4 | -526 | -328 | -89.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -520 | -92.4 | -526 | -328 | -89.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.987 | -0.178 | -1.16 | -0.571 | -0.156 |
| Dividends per Share |